Back to Report Store Home

Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future

  • Published: Oct-2011
  • Report Code: GBIHC143MR
  • Report Format: pdf

Description

List of Figures

Figure 1: Contraceptives Market, Global, Revenue Forecasts, ($bn), 2002–2017

Figure 2: Contraceptives Market, Global, Product Pipeline by Phase, (%), 2011

Figure 3: Contraceptives Market, Global, Revenue Forecasts, ($bn), 2002–2017

Figure 4: Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($bn), 2002–2017

Figure 5: Contraceptives Market, Global, Annual Cost of Usage, ($), 2002–2017

Figure 6: Contraceptives Market, Global, Share of Prescription and OTC Contraceptives, (%), 2010

Figure 7: Contraceptives Market, Global, Drivers and Barriers, 2011

Figure 8: Contraceptives Market, The US, Revenue Forecasts, ($bn), 2002–2017

Figure 9: Contraceptives Market, The US, Annual Cost of Usage, ($), 2002–2017

Figure 10: Contraceptives Market, Top Five Countries of Europe, Revenue Forecasts, ($bn), 2002–2017

Figure 11: Contraceptives Market, Top Five Countries of Europe, Annual Cost of Usage, ($), 2002–2017

Figure 12: Contraceptives Market, Japan, Revenue Forecasts, ($m), 2002–2017

Figure 13: Contraceptives Market, Japan, Annual Cost of Usage, ($), 2002–2017

Figure 14: Oral Contraceptives Market, Global, Revenue Forecasts, ($m), 2002–2017

Figure 15: Oral Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002–2017

Figure 16: Oral Contraceptives Market, Global, Annual Cost of Therapy, ($), 2002–2017

Figure 17: Oral Contraceptives Market, Global, Treatment Usage Patterns Forecasts, (Million), 2002–2017

Figure 18: Injectables Market, Global, Revenue Forecasts, ($m), 2002–2017

Figure 19: Injectables Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002–2017

Figure 20: Injectables Market, Global, Annual Cost of Therapy, ($), 2002–2017

Figure 21: Injectables Market, Global, Treatment Usage Patterns Forecasts, (‘000), 2002–2017

Figure 22: Topical Contraceptives Market, Global, Revenue Forecasts, ($m), 2002–2017

Figure 23: Topical Contraceptives Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002–2017

Figure 24: Topical Contraceptives Market, Global, Annual Cost of Therapy, ($), 2002–2017

Figure 25: Topical Contraceptives Market, Global, Treatment Usage Patterns Forecasts, (‘000), 2002–2017

Figure 26: Vaginal Ring Market, Global, Revenue Forecasts, ($m), 2002–2017

Figure 27: Vaginal Ring Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002–2017

Figure 28: Vaginal Ring Market, Global, Annual Cost of Usage, ($), 2002–2017

Figure 29: Intrauterine Devices Market, Global, Revenue Forecasts, ($m), 2002–2017

Figure 30: Intrauterine Devices Market, Global, Share of Hormonal and Copper Intrauterine Device, (%), 2010

Figure 31: Intrauterine Devices Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002–2017

Figure 32: Intrauterine Devices Market, Global, Annual Cost of Usage, ($), 2002–2017

Figure 33: Condoms Market, Global, Revenue Forecasts, ($m), 2002–2017

Figure 34: Condoms Market, Global, Revenue Forecasts by Geographical Segmentation, ($m), 2002–2017

Figure 35: Condoms Market, Global, Annual Cost of Usage, ($), 2002–2017

Figure 36: Contraceptives Market, Global, Product Pipeline by Phase, (%), 2011

Figure 37: Contraceptives Market, Global, Market Share Analysis, (%), 2011

Figure 38: Contraceptives Market, Global, Bayer Company Profile, 2011

Figure 39: Contraceptives Market, Global, Bayer, SWOT Analysis, 2011

Figure 40: Contraceptives Market, Global, Johnson & Johnson Company Profile, 2011

Figure 41: Contraceptives Market, Global, Johnson & Johnson, SWOT Analysis, 2011

Figure 42: Contraceptives Market, Global, Church & Dwight Company Profile, 2011

Figure 43: Contraceptives Market, Global, Church & Dwight, SWOT Analysis, 2011

Figure 44: Contraceptives Market, Global, Merck Company Profile, 2011

Figure 45: Contraceptives Market, Global, Merck, SWOT Analysis, 2011

Figure 46: Contraceptives Market, Global, Reckitt Benckiser Company Profile, 2011

Figure 47: Contraceptives Market, Global, Reckitt Benckiser, SWOT Analysis, 2011

Figure 48: Contraceptives Market, Global, M&A Deals by Year, 2000–2011

Figure 49: Contraceptives Market, Global, M&A Deals by Value (%), 2000–2011

Figure 50: Contraceptives Market, Global, M&A Deals by Geography (%), 2000–2011

Figure 51: Contraceptives Market, Global, M&A Deals by Deal Type (%), 2000–2011

Figure 52: Contraceptives Market, Global, Deals by Deal Sub-Type (%), 2000–2011

Figure 53: Contraceptives Market, Global, Licensing Agreements by Year, 2004–2011

Figure 54: Contraceptives Market, Global, Licensing Agreements by Geography (%), 2004–2011

Figure 55: Contraceptives Market, Global, Licensing Agreements by Value (%), 2004–2011

Figure 56: Contraceptives Market, Global, Co-Development Agreements by Year, 2006–2011

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards